Speaker(s): 

Heidi Cope, M.S., CGC- Senior Research Genetic Counselor -RTI International- has nothing to disclose.

Moderator(s): 

None

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Identify methods to scale genomic newborn screening for state-wide implementation.
• Recognize benefits and limitations of screening newborns for type 1 diabetes risk using a genetic risk score.
• Discuss clinical utility and follow-up metrics for screen positive participants.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Adam Buchanan, MS, MPH, LCGC, Juliann Savatt, MS, LCGC, Melissa Kelly, MS, LCGC, Marc Williams, MD, and Cara McCormick, MPH have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None